Results of the TOMAHAWK trial show that immediate transfer for angiography after out-of-hospital arrest without ST-segment elevation provided no mortality advantage over a delayed or more selective approach.
People infected with the Delta variant of COVID-19 carry twice the risk of needing to be treated in hospital than those with the Alpha strain, a study has suggested.
New report recommends a top to bottom reorganization of the process to promote equity, standardize student evaluations, and reduce reliance on medical licensing exam scores.
The largest study to date confirms that a substantial number of COVID-19 survivors have persistent problems. One researcher calls it a “modern medical challenge of the first order.”
In a large platform trial of high-risk COVID-19 outpatients in Brazil, a 10-day course of fluvoxamine reduced emergency department and hospital admissions by nearly a third.
Polygenic risk scores for assessing individual risk for disease is plagued by one glaring omission: the lack of applicability to those of non-European ancestry.
Used more broadly than now indicated for the PA pressure monitor implant, the strategy may have cut some prepandemic HF admissions. But the trial’s course shifted in March 2020, researchers say.
A Baltimore physician assistant knew patients didn’t legitimately need the prescriptions and said he tried to lower their doses. He claimed in his plea agreement that he was overruled by the practice’s owners.
Frank Herd 